{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:55:13Z","timestamp":1792896913913,"version":"4.5.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/pas.0000000000000453","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T12:53:09Z","timestamp":1432990389000},"page":"1075-1084","source":"Crossref","is-referenced-by-count":194,"title":["Ipilimumab-associated Hepatitis"],"prefix":"10.1097","volume":"39","author":[{"given":"Melanie","family":"Johncilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Misdraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agoston T.","family":"Agoston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.","family":"Lauwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabh","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leona A.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri2216","article-title":". Immunological aspects of cancer chemotherapy.","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"R2-8-20210131","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2051","article-title":". Immunostimulatory monoclonal antibodies for cancer therapy.","volume":"7","author":"Melero","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R3-8-20210131","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/cncr.23086","article-title":"Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4): a novel strategy for the treatment of melanoma and other malignancies.","volume":"110","author":"ODay","year":"2007","journal-title":"Cancer"},{"key":"R4-8-20210131","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":". Improved survival with ipilimumab in patients with metastatic melanoma.","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-8-20210131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/annonc\/mds213","article-title":". Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial.","volume":"24","author":"Reck","year":"2013","journal-title":"Ann Oncol"},{"key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1158\/1078-0432.CCR-06-2318","article-title":". A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.","volume":"13","author":"Small","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/PAS.0b013e31817150e3","article-title":". Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis.","volume":"32","author":"Oble","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R10-8-20210131","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1055\/s-0033-1355337","article-title":". Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy.","volume":"121","author":"Lammert","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/practneurol-2012-000447","article-title":". Neurological immune-related adverse events of ipilimumab.","volume":"4","author":"Bot","year":"2013","journal-title":"Pract Neurol"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamadermatol.2014.2233","article-title":". Drug-associated dermatomyositis following ipilimumab therapy: a novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade.","volume":"151","author":"Sheik Ali","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R13-8-20210131","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune-related adverse events and kinetics of response with ipilimumab.","volume":"30","author":"Weber","year":"2012","journal-title":"J Clin Oncol"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10637-013-9939-6","article-title":". Ipilimumab associated hepatitis: imaging and clinicopathologic findings.","volume":"4","author":"Kim","year":"2013","journal-title":"Invest New Drugs"},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s10620-012-2140-5","article-title":"Pathologic changes in ipilimumab-related hepatitis in patients with metastatic melanoma.","volume":"8","author":"Kleiner","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.med.56.082103.104549","article-title":"Effective cancer therapy through immunomodulation.","volume":"57","author":"Waldmann","year":"2006","journal-title":"Annu Rev Med"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":". Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.","volume":"210","author":"Simpson","year":"2013","journal-title":"J Exp Med"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1053\/gast.1997.v113.pm9247489","article-title":". A novel histological lesion in glucocorticoid-responsive chronic hepatitis.","volume":"113","author":"Pratt","year":"1997","journal-title":"Gastroenterology"},{"key":"R19-8-20210131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis.","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"R20-8-20210131","first-page":"S21","article-title":"Acute and chronic hepatic allograft rejection: pathology and classification.","volume":"4","author":"Batts","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1600-6143.2008.02300.x","article-title":". New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25CD4 regulatory T cells.","volume":"8","author":"Li","year":"2008","journal-title":"Am J Transplant"},{"key":"R22-8-20210131","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/adc.67.12.1447","article-title":". Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.","volume":"67","author":"Senaldi","year":"1992","journal-title":"Arch Dis Child"},{"key":"R23-8-20210131","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis.","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R24-8-20210131","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Van Damme-Lombaerts R, et al.. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages.","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"key":"R25-8-20210131","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/pbc.21423","article-title":". Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.","volume":"50","author":"Allen","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R26-8-20210131","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/PAS.0b013e3181dbbb17","article-title":". Pathology of the liver in familial hemophagocytic lymphohistiocytosis.","volume":"34","author":"Chen","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R27-8-20210131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.510250119","article-title":". Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study.","volume":"25","author":"Chien","year":"1997","journal-title":"Hepatology"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:45:06Z","timestamp":1620967506000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201508000-00008"}},"subtitle":["Clinicopathologic Characterization in a Series of 11 Cases"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000453","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}